In 2024, the global resuscitation devices market was valued at USD 5.06 billion and is projected to grow from USD 5.38 billion in 2025 to USD 9.00 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.6% over the forecast period.

The resuscitation devices market encompasses a wide range of medical equipment used to restore breathing and circulation in patients experiencing respiratory or cardiac arrest. These devices play a critical role in emergency medical services, hospitals, and trauma care settings. With the growing burden of cardiovascular and respiratory diseases, coupled with increasing awareness about timely medical intervention, the demand for effective resuscitation solutions is on the rise. Advancements in technology have led to the development of more efficient, portable, and user-friendly devices, improving outcomes in both pre-hospital and in-hospital scenarios. As healthcare systems around the world focus on strengthening emergency response capabilities, the resuscitation devices market is expected to continue evolving with innovations aimed at improving speed, accuracy, and accessibility in life-saving interventions.

Tariff Impact Analysis for Resuscitation Devices Market:

https://www.fortunebusinessinsights.com/resuscitation-devices-market-109515

Resuscitation Devices Market Overview:

The resuscitation devices market is witnessing steady expansion due to the rising incidence of cardiac arrests, respiratory failures, and emergency medical conditions. Growing awareness about the importance of early resuscitation and increased investment in emergency care infrastructure is driving the adoption of advanced resuscitation equipment. Innovations in automated resuscitators, portable defibrillators, and hybrid ventilation systems are contributing to the transformation of emergency response protocols across hospitals and pre-hospital settings.

List Of Top Resuscitation Devices Market Companies:

• Koninklijke Philips N.V. (Netherlands)

• Hamilton Medical (Switzerland)

• Getinge AB (Sweden)

• Medtronic (Ireland)

• Teleflex Incorporated (U.S.)

• Convatec Group PLC (U.K.)

• Ambu A/S (Denmark)

• Flexicare Medical Limited (U.K.)

• ICU Medical (U.S.)

• ZOLL Medical Corporation (Asahi Kasei) (U.S.)

• Stryker (U.S.)

Market Segmentation:

The resuscitation devices market is segmented based on product type, patient type, end-user, and region. By product type, the market includes manual resuscitators, automatic resuscitators, defibrillators, airway management devices, and cardiopulmonary resuscitation (CPR) devices, each catering to different emergency needs. In terms of patient type, the market is divided into adult and pediatric segments, reflecting the varying clinical requirements and equipment specifications for different age groups. Based on end-users, the resuscitation devices market serves hospitals, ambulatory surgical centers, emergency medical services (EMS), and military or defense medical units, with each setting demanding unique device capabilities. Regionally, the market spans North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with adoption levels influenced by healthcare infrastructure, economic conditions, and government initiatives. These segmentation factors together shape the demand dynamics and strategic development of the resuscitation devices market.

Market Growth:

The resuscitation devices market is experiencing consistent growth driven by the increasing demand for rapid-response medical equipment. The rise in aging populations, chronic respiratory diseases, and global health emergencies has created a greater reliance on these devices. Additionally, the expanding scope of emergency medical services (EMS) and improved training for first responders have boosted the market’s momentum. Technological advancements that enhance portability, automation, and ease of use further contribute to the expansion of the resuscitation devices market.

Restraining Factors

Despite its positive outlook, the resuscitation devices market faces several restraining factors. High costs associated with advanced equipment can limit adoption in low-resource settings. A lack of skilled healthcare professionals and inadequate training in using sophisticated resuscitation technologies can also hinder effective utilization. Furthermore, regulatory hurdles and concerns about device malfunctions or product recalls may slow down market penetration in certain regions.

Regional Analysis

Regionally, the resuscitation devices market shows varying degrees of growth. North America dominates due to a well-established emergency care system, strong healthcare infrastructure, and continuous R&D initiatives. Europe follows with robust investment in hospital upgrades and emergency preparedness. Asia Pacific is emerging as a high-potential region due to a rising patient population, improving healthcare access, and expanding EMS networks. Latin America and the Middle East & Africa are also gradually adopting resuscitation devices as healthcare reforms and international aid improve emergency response capabilities.

Key Industry Developments:

In July 2023, Ambu A/S announced that its lung ventilation device, VivaSight 2 SLT, is prepared for commercialization in the European market.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baner - Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India.

Phone:

U.S.: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com